Oncology News

Cancer immunotherapy biotech firm Jounce Therapeutics, the creation of Third Rock Ventures, has appointed a former vice president of biologics and vaccines as its first permanent CEO.

Rieli Biggins, nine, underwent three years of chemotherapy to help overcome the acute lymphoblastic leukaemia he was diagnosed with at the age of three.

More scientific research into the metabolism of stromal support cells and immune cells -- and the role of the metabolism of these cell types in the development of diseases -- could open new therapeutic avenues for diabetes, inflammatory conditions and cancer, scientists conclude.

There has been a sharp increase in the number of cancer patients at one hospital using MyChart, the online, interactive service that allows patients to view laboratory and radiology results, communicate with their healthcare providers, and more.

The drug exemestane worked slightly better than the drug tamoxifen at preventing a recurrence of breast cancer in certain premenopausal women, according to a new study.

In March, Schoolcraft Memorial Hospital was on the verge of losing its Oncology Department.

Michael W. Stein, MHSA, CMPE, was named as executive director of oncology services at Greater Baltimore Medical Center.

For nearly five months now, my dog Cardiff has been undergoing chemotherapy treatment for lymphoma.

They currently have a $3.80 price target on the stock. Zacks 's price target suggests a potential upside of 6.15% from the stock's previous close.

Keck Medicine of USC has acquired an oncology business as part of an expansion into Orange County.

The reasons for eating a healthy diet are obvious but have you ever thought about the relationship your diet has to cancer? One doctor think there is a strong link and hopes that people change their minds about that link in the next few years.

Threshold Pharmaceuticals, Inc. today announced that dosing has started in the final stage of an ongoing Phase 1/2 trial of its investigational hypoxia-activated prodrug, TH-302, in combination with the proteasome inhibitor bortezomib and low-dose dexamethasone in patients with relapsed/refractory multiple myeloma, a cancer of the bone marrow.

Researchers at Roswell Park Cancer Institute have identified a mechanism of breast cancer cells that leads to chemotherapy resistance in inflammatory breast cancer.

Key genetic variants may affect how cancer patients respond to radiation treatments, according to a study.

A treatment approach based on comprehensive care for some cancer patients in Fort Worth and four other cities led to a one-third cut in spending without compromising quality, according to the latest Journal of Oncology Practice .

The firm currently has a $7.20 price target on the stock. They noted that the move was a valuation call.

Oncology has long been one of the most active areas in pharmaceutical research, because new drugs tend to have high profit margins and long shelf lives and are often amenable to broad label expansions for a diversity of cancer types.

Watching my wife deal with morning sickness while I was laid low by chemoA therapy, I realized that I had the easier job.

One of the great health-care challenges of the next few years is getting control of the skyrocketing costs of treating cancer.

Actinium Pharmaceuticals, Inc. , a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced the addition of M. Yair Levy, MD of Baylor to its Scientific Advisory Board for Iomaba -B.